Caricamento...
Trials in type 1 diabetes: Antigen-specific therapies
Type 1 diabetes (T1D) results from an aberrant immunological response against the insulin-producing beta cells in the islets of the pancreas. The ideal therapy would restore immune balance in a safe and lasting fashion, stopping the process of beta cell decay. The efficacy of immune suppressive agen...
Salvato in:
| Pubblicato in: | Clin Immunol |
|---|---|
| Autori principali: | , , |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
2013
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5777514/ https://ncbi.nlm.nih.gov/pubmed/23490422 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.clim.2013.02.002 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|